Shanghai - Delayed Quote CNY
TALOPH PHARM (600222.SS)
5.37
+0.01
+(0.19%)
At close: May 23 at 3:00:02 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,765,582.75
1,941,420.11
2,069,908.74
1,960,694.31
1,604,516.94
Cost of Revenue
1,318,548.81
1,444,561.46
1,505,186.41
1,488,613.65
1,141,450.23
Gross Profit
447,033.94
496,858.65
564,722.33
472,080.66
463,066.71
Operating Expense
369,933.22
410,575.21
458,315.63
429,455.65
305,972.84
Operating Income
77,100.72
86,283.43
106,406.69
42,625
157,093.87
Net Non Operating Interest Income Expense
-1,484.43
-1,267.52
-1,736.23
-2,990.67
-5,897.08
Pretax Income
20,824.62
35,074.25
42,962.47
-82,849.05
7,450.04
Tax Provision
-14,780.56
-18,421.21
-1,866.82
-7,086.38
671.41
Net Income Common Stockholders
30,797.25
50,525.32
43,556.72
-72,203.91
5,995.38
Basic EPS
0.06
--
0.08
-0.13
0.01
Diluted EPS
0.06
--
0.08
-0.13
0.01
Basic Average Shares
553,611.91
--
562,748.38
562,335.75
560,315.47
Diluted Average Shares
553,611.91
--
562,748.38
562,335.75
560,315.47
Total Operating Income as Reported
21,457.58
35,719.33
44,166.52
-70,779.32
35,607.98
Total Expenses
1,688,482.03
1,855,136.68
1,963,502.04
1,918,069.31
1,447,423.07
Net Income from Continuing & Discontinued Operation
30,797.25
50,525.32
43,556.72
-72,203.91
5,995.38
Normalized Income
29,557.48
47,304.60
45,669.56
-29,278.26
43,403.97
Interest Income
3,606.24
3,638.21
2,168.53
2,216.11
3,087.01
Interest Expense
3,143.53
2,497.09
917.43
4,068.26
5,713.60
Net Interest Income
-1,484.43
-1,267.52
-1,736.23
-2,990.67
-5,897.08
EBIT
23,968.15
37,571.34
43,879.90
-78,780.79
13,163.64
EBITDA
23,968.15
102,514
111,808.21
-15,797
70,348.22
Reconciled Cost of Revenue
1,318,548.81
1,444,561.46
1,505,186.41
1,488,613.65
1,141,450.23
Reconciled Depreciation
--
64,942.66
67,928.32
62,983.79
57,184.58
Net Income from Continuing Operation Net Minority Interest
30,797.25
50,525.32
43,556.72
-72,203.91
5,995.38
Total Unusual Items Excluding Goodwill
2,066.29
4,294.29
-2,817.12
-46,940.65
-41,113.81
Total Unusual Items
2,066.29
4,294.29
-2,817.12
-46,940.65
-41,113.81
Normalized EBITDA
21,901.86
98,219.72
114,625.33
31,143.65
111,462.04
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
826.52
1,073.57
-704.28
-4,015
-3,705.22
12/31/2021 - 11/5/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade